Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker

Y Wang, T Liu - Magnetic resonance in medicine, 2015 - Wiley Online Library
In MRI, the main magnetic field polarizes the electron cloud of a molecule, generating a
chemical shift for observer protons within the molecule and a magnetic susceptibility …

Iron and chelation in biochemistry and medicine: new approaches to controlling iron metabolism and treating related diseases

GJ Kontoghiorghes, CN Kontoghiorghe - Cells, 2020 - mdpi.com
Iron is essential for all living organisms. Many iron-containing proteins and metabolic
pathways play a key role in almost all cellular and physiological functions. The diversity of …

Targeting chelatable iron as a therapeutic modality in Parkinson's disease

D Devos, C Moreau, JC Devedjian, J Kluza… - Antioxidants & redox …, 2014 - liebertpub.com
Aims: The pathophysiological role of iron in Parkinson's disease (PD) was assessed by a
chelation strategy aimed at reducing oxidative damage associated with regional iron …

A delicate balance: Iron metabolism and diseases of the brain

D Hare, S Ayton, A Bush, P Lei - Frontiers in aging neuroscience, 2013 - frontiersin.org
Iron is the most abundant transition metal within the brain, and is vital for a number of
cellular processes including neurotransmitter synthesis, myelination of neurons, and …

[HTML][HTML] Parkinson's disease: alterations in iron and redox biology as a key to unlock therapeutic strategies

L Ma, MG Azad, M Dharmasivam, V Richardson… - Redox biology, 2021 - Elsevier
A plethora of studies indicate that iron metabolism is dysregulated in Parkinson's disease
(PD). The literature reveals well-documented alterations consistent with established dogma …

The 'swallow tail'appearance of the healthy nigrosome–a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T

ST Schwarz, M Afzal, PS Morgan, N Bajaj… - PloS one, 2014 - journals.plos.org
There is no well-established in vivo marker of nigral degeneration in Parkinson's disease
(PD). An ideal imaging marker would directly mirror the loss of substantia nigra …

The relevance of iron in the pathogenesis of Parkinson's disease

J Sian‐Hülsmann, S Mandel… - Journal of …, 2011 - Wiley Online Library
J. Neurochem.(2011) 118, 939–957. Abstract Alterations of iron levels in the brain has been
observed and documented in a number of neurodegenerative disorders including …

Region‐specific disturbed iron distribution in early idiopathic P arkinson's disease measured by quantitative susceptibility mapping

N He, H Ling, B Ding, J Huang, Y Zhang… - Human brain …, 2015 - Wiley Online Library
In Parkinson's disease (PD), iron elevation in specific brain regions as well as selective loss
of dopaminergic neurons is a major pathologic feature. A reliable quantitative measure of …

The aging of iron man

A Ashraf, M Clark, PW So - Frontiers in aging neuroscience, 2018 - frontiersin.org
Brain iron is tightly regulated by a multitude of proteins to ensure homeostasis. Iron
dyshomeostasis has become a molecular signature associated with aging which is …

Brain iron metabolism dysfunction in Parkinson's disease

H Jiang, J Wang, J Rogers, J Xie - Molecular neurobiology, 2017 - Springer
Dysfunction of iron metabolism, which includes its uptake, storage, and release, plays a key
role in neurodegenerative disorders, including Parkinson's disease (PD), Alzheimer's …